Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque

Alexander Niessner1, Bernhard Richter, Martina Penka

  • 1Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. alexander.niessner@meduniwien.ac.at

Atherosclerosis
|August 9, 2005
PubMed

Insights

Endurance training significantly reduces inflammatory markers like IL-8 and MMP-9 in individuals with coronary artery disease (CAD). This effect is more pronounced in diabetic patients and those on statin therapy, suggesting benefits for cardiovascular health.

Area of Science:

  • Cardiovascular Disease Research
  • Exercise Physiology
  • Inflammation Biology

Background:

  • Inflammatory pathways play a crucial role in the destabilization of atherosclerotic plaques.
  • Understanding the impact of exercise on inflammatory markers is vital for managing cardiovascular disease (CAD).

Purpose of the Study:

  • To investigate the effect of a 12-week supervised endurance training program on circulating inflammatory markers in individuals with CAD and/or cardiovascular risk factors (CVRFs).
  • To assess whether diabetes mellitus (DM) or statin use influences the changes in inflammatory markers in response to endurance training.

Main Methods:

  • Thirty-two subjects with CAD and/or CVRFs participated in a 12-week supervised endurance training program.
  • Circulating concentrations of chemokines (interleukin-8, monocyte chemoattractant protein-1), matrix metalloproteinase-9 (MMP-9), and acute phase reactants (interleukin-6, high-sensitivity C-reactive protein) were measured before and after training.
  • Statistical analyses were performed to determine significant changes and the influence of factors like DM and statin use.

Main Results:

  • Endurance training led to significant decreases in interleukin-8 (IL-8) by 21% and monocyte chemoattractant protein-1 (MCP-1) by 5%.
  • Matrix metalloproteinase-9 (MMP-9) significantly decreased by 18% following the training program.
  • The reduction in IL-8 was significantly greater in diabetic patients (39% decrease), and MMP-9 reduction was more pronounced in patients taking statins (44% decrease).
  • No significant changes were observed in interleukin-6 (IL-6) or high-sensitivity C-reactive protein (hs-CRP).

Conclusions:

  • Endurance training effectively reduces circulating levels of key inflammatory chemokines and MMP-9 in individuals with CAD and CVRFs.
  • These reductions may contribute to the beneficial effects of endurance training on coronary risk.
  • Patients with DM and those on statin therapy may experience particularly significant benefits from endurance training regarding these inflammatory markers.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...